Back
Nascent Biotech, Inc. 10K Form
Sell
17
NBIO
Nascent Biotech, Inc.
Last Price:
$0.0000
Seasonality Move:
-14.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-07 | 10Q | NBIO/Nascent Biotech, Inc. Quarterly |
| 2020-06-22 | 10K | NBIO/Nascent Biotech, Inc. Annual |
| 2020-02-11 | 10Q | NBIO/Nascent Biotech, Inc. Quarterly |
| 2019-11-18 | 10Q | NBIO/Nascent Biotech, Inc. Quarterly |
| 2019-08-13 | 10Q | NBIO/Nascent Biotech, Inc. Quarterly |
| 2019-07-12 | 10K | NBIO/Nascent Biotech, Inc. Annual |
Receive NBIO News And Ratings
See the #1 stock for the next 7 days that we like better than NBIO
NBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-324.7K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.01340 |
|---|---|
| Net Income (TTM): | $-1.9M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Nascent Biotech, Inc. Earnings Forecast
Key Nascent Biotech, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 6 years.
Nascent Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | NBIO |
| Website: | nascentbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NBIO Technical Analysis vs Fundamental Analysis
Sell
17
Nascent Biotech, Inc. (NBIO)
is a Sell
Is Nascent Biotech, Inc. a Buy or a Sell?
-
Nascent Biotech, Inc. stock is rated a SellThe current Nascent Biotech, Inc. [NBIO] share price is $0.0002. The Score for NBIO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.